# HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY

> **NIH NIH N01** · MESO SCALE DIAGNOSTICS, LLC · 2021 · $112,946

## Abstract

The goal of the program is to develop a high throughput biodosimetry test suitable for use in mass casualty situations following a radiological/nuclear incident. The device, the UHT Biodosimetry Test, will quantitate six blood biomarkers in patient plasma samples using multiplexed immunoassays and apply a multi-parameter algorithm to estimate absorbed radiation dose. The radiation markers have been developed and tested during MSD’s on-going biodosimetry program to develop a triage test

## Key facts

- **NIH application ID:** 10382187
- **Project number:** 272201700013C-P00010-9999-1
- **Recipient organization:** MESO SCALE DIAGNOSTICS, LLC
- **Principal Investigator:** GEORGE SIGAL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $112,946
- **Award type:** —
- **Project period:** 2017-03-15 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10382187

## Citation

> US National Institutes of Health, RePORTER application 10382187, HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY (272201700013C-P00010-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10382187. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*